•
Sep 30, 2021

ARS Pharmaceuticals Q3 2021 Earnings Report

Total Revenue
$528K
EPS
-$1.89
Cash and Equivalents
$301M
Free Cash Flow
-$19.2M
Total Assets
$353M

ARS Pharmaceuticals

ARS Pharmaceuticals